Tyrosine kinase inhibitors: Rationale, mechanisms of action, and implications for drug resistance

被引:26
作者
Busse, D
Yakes, FM
Lenferink, AEG
Arteaga, CL
机构
[1] Vanderbilt Univ, Sch Med, Div Oncol, Dept Med, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Cell Biol, Nashville, TN 37232 USA
[3] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA
[4] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
关键词
D O I
10.1053/sonc.2001.28550
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:47 / 55
页数:9
相关论文
共 45 条
  • [1] ALIMANDI M, 1995, ONCOGENE, V10, P1813
  • [2] The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions
    Alroy, I
    Yarden, Y
    [J]. FEBS LETTERS, 1997, 410 (01) : 83 - 86
  • [3] Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site
    Arteaga, CL
    Ramsey, TT
    Shawver, LK
    Guyer, CA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (37) : 23247 - 23254
  • [4] ARTEAGA CL, 1994, CANCER RES, V54, P4703
  • [5] ARTEAGA CL, IN PRESS SEMIN ONCOL
  • [6] Baselga J, 1998, CANCER RES, V58, P2825
  • [7] ONCOGENES AND THE STRATEGY OF GROWTH-FACTORS
    BASERGA, R
    [J]. CELL, 1994, 79 (06) : 927 - 930
  • [8] BOS M, 1997, CLIN CANCER RES, V3, P2009
  • [9] Reversible G1 arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27KIP1 independent of MAPK activity
    Busse, D
    Doughty, RS
    Ramsey, TT
    Russell, WE
    Price, JO
    Flanagan, WM
    Shawver, LK
    Arteaga, CL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (10) : 6987 - 6995
  • [10] Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease
    Cobleigh, MA
    Vogel, CL
    Tripathy, D
    Robert, NJ
    Scholl, S
    Fehrenbacher, L
    Wolter, JM
    Paton, V
    Shak, S
    Lieberman, G
    Slamon, DJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) : 2639 - 2648